<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
NOVARTIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Novartis India Ltd has filed an initial disclosure under the Large Corporate framework as mandated by SEBI. The actual disclosure details and table data were not accessible as the BSE page returned an error (page moved). This filing appears to be a regulatory compliance submission related to SEBI's guidelines for entities classified as Large Corporates, which require specific disclosure norms regarding borrowings and outstanding loans.
This is a routine regulatory compliance filing and does not directly impact the stock price or operations. It indicates Novartis India Ltd falls under SEBI's Large Corporate category, requiring enhanced disclosure norms.